Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vioxx Promotions, Labeling Revisions Are Focus Of Drug Safety Hearing

May 03 2005

• By Andrew Dove

Related Content

FDA Safety Act Proposes Fines For Failure To Comply With Drug Safety Office

Apr 27 2005

FDA Drug Safety Oversight Board Will Include VA, Other Agencies

Feb 15 2005

FDA Gives 50% Of Focus To Drug Safety Under PDUFA, Agency’s Woodcock Says

Mar 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window